56 results
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
10 May 23
Other Events
8:08am
LLP (“MWE”) in connection with the First Omnibus Order Awarding Interim Allowance of Compensation for Services Rendered and For Reimbursement
8-K
EX-10.1
PHASQ
PhaseBio Pharmaceuticals Inc
8 Nov 22
Entry into a Material Definitive Agreement
5:21pm
of reimbursement, rights of indemnity or contribution and other similar rights (known and unknown, matured and unmatured, accrued or contingent, regardless … and reimbursement obligations to guarantors of Seller’s obligations or under letters of credit or other similar agreements or instruments; (f) all Liabilities
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
24 Oct 22
Bankruptcy or Receivership
8:02am
of $2 million and reimbursement of expenses of up to $750,000, to be paid from the proceeds of a sale to an alternative purchaser.
"The Board
424B5
lt9lp4
12 Nov 21
Prospectus supplement for primary offering
4:09pm
8-K
EX-1.1
u0bqhynoedbqeq0gmz40
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
8-K
EX-99.2
8yfru8tcw
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am
8-K
EX-99.1
3cvmivwxl15zn
12 May 20
PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights
4:08pm